Cargando…

Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: One of the most significant risk factors for atrial fibrillation is hypertension (HTN) (AF). Although the PR interval is a factor in the Framingham risk score for AF, it has been linked to an elevated risk of incident AF. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Papakonstantinou, P, Andrikou, I, Konstantinidis, D, Tsioufis, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207229/
http://dx.doi.org/10.1093/europace/euad122.034
_version_ 1785046405570625536
author Papakonstantinou, P
Andrikou, I
Konstantinidis, D
Tsioufis, K
author_facet Papakonstantinou, P
Andrikou, I
Konstantinidis, D
Tsioufis, K
author_sort Papakonstantinou, P
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: One of the most significant risk factors for atrial fibrillation is hypertension (HTN) (AF). Although the PR interval is a factor in the Framingham risk score for AF, it has been linked to an elevated risk of incident AF. However, there is a lack of consistency in the findings identifying PR prolongation as a risk factor for AF. PURPOSE: In a large cohort of HTN patients, we seek to assess the predictive value of the PR interval for the emergence of AF. METHODS: The average follow-up time for consecutive individuals with essential hypertension and no known AF at baseline was 5.3 years. Each patient underwent a 12-lead ECG, an echocardiogram examination, and a 24-hour Holter rhythm monitoring in the event of arrhythmia complaints. These tests were done at baseline and once a year. The European Society of Cardiology/European Society of Hypertension guidelines for HTN therapy were followed during the follow-up period, including routine clinical and paraclinical assessments and drug administration. The baseline ECG was used to determine the PR interval and P wave length. RESULTS: We included 1807 hypertensives (mean age 57±11 years; 49% men) with office systolic/diastolic blood pressure of 144±17/89±11 mmHg. A total of 65 occurrences of new-onset AF (3%) were reported during the follow-up period. P wave duration and PR internal time were longer at baseline in patients with new-onset AF (n=67) compared to those without AF (n=1740) (P wave, 115 vs 110 ms) (PR interval, 174 vs 157 ms). A multivariate Cox regression analysis showed that baseline P wave duration had no significant prognostic value for the occurrence of new-onset AF, but baseline PR internal was substantially linked with the development of AF (HR = 1.01, 95% CI = 1.01-1.02; p = 0.01). A greater incidence of AF was linked to baseline elevated diastolic blood pressure (HR 1.05, 95% 1.003-1.091; p=0.037). CONCLUSIONS: Baseline PR internal and elevated diastolic blood pressure were significant predictors of new-onset AF in hypertensive patients. PR prolongation may be a marker for cardiovascular degenerative aging caused by vascular inflammation and myocardial fibrosis.
format Online
Article
Text
id pubmed-10207229
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102072292023-05-25 Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients Papakonstantinou, P Andrikou, I Konstantinidis, D Tsioufis, K Europace 10.2.1 - Prevalence and Incidence of Atrial Fibrillation FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: One of the most significant risk factors for atrial fibrillation is hypertension (HTN) (AF). Although the PR interval is a factor in the Framingham risk score for AF, it has been linked to an elevated risk of incident AF. However, there is a lack of consistency in the findings identifying PR prolongation as a risk factor for AF. PURPOSE: In a large cohort of HTN patients, we seek to assess the predictive value of the PR interval for the emergence of AF. METHODS: The average follow-up time for consecutive individuals with essential hypertension and no known AF at baseline was 5.3 years. Each patient underwent a 12-lead ECG, an echocardiogram examination, and a 24-hour Holter rhythm monitoring in the event of arrhythmia complaints. These tests were done at baseline and once a year. The European Society of Cardiology/European Society of Hypertension guidelines for HTN therapy were followed during the follow-up period, including routine clinical and paraclinical assessments and drug administration. The baseline ECG was used to determine the PR interval and P wave length. RESULTS: We included 1807 hypertensives (mean age 57±11 years; 49% men) with office systolic/diastolic blood pressure of 144±17/89±11 mmHg. A total of 65 occurrences of new-onset AF (3%) were reported during the follow-up period. P wave duration and PR internal time were longer at baseline in patients with new-onset AF (n=67) compared to those without AF (n=1740) (P wave, 115 vs 110 ms) (PR interval, 174 vs 157 ms). A multivariate Cox regression analysis showed that baseline P wave duration had no significant prognostic value for the occurrence of new-onset AF, but baseline PR internal was substantially linked with the development of AF (HR = 1.01, 95% CI = 1.01-1.02; p = 0.01). A greater incidence of AF was linked to baseline elevated diastolic blood pressure (HR 1.05, 95% 1.003-1.091; p=0.037). CONCLUSIONS: Baseline PR internal and elevated diastolic blood pressure were significant predictors of new-onset AF in hypertensive patients. PR prolongation may be a marker for cardiovascular degenerative aging caused by vascular inflammation and myocardial fibrosis. Oxford University Press 2023-05-24 /pmc/articles/PMC10207229/ http://dx.doi.org/10.1093/europace/euad122.034 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.2.1 - Prevalence and Incidence of Atrial Fibrillation
Papakonstantinou, P
Andrikou, I
Konstantinidis, D
Tsioufis, K
Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
title Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
title_full Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
title_fullStr Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
title_full_unstemmed Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
title_short Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
title_sort baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
topic 10.2.1 - Prevalence and Incidence of Atrial Fibrillation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207229/
http://dx.doi.org/10.1093/europace/euad122.034
work_keys_str_mv AT papakonstantinoup baselineprinternalprolongationandelevateddiastolicbloodpressurearepredictorsofnewonsetatrialfibrillationinhypertensivepatients
AT andrikoui baselineprinternalprolongationandelevateddiastolicbloodpressurearepredictorsofnewonsetatrialfibrillationinhypertensivepatients
AT konstantinidisd baselineprinternalprolongationandelevateddiastolicbloodpressurearepredictorsofnewonsetatrialfibrillationinhypertensivepatients
AT tsioufisk baselineprinternalprolongationandelevateddiastolicbloodpressurearepredictorsofnewonsetatrialfibrillationinhypertensivepatients